Diagnostic Molecular Markers for Endometrial Cancer
Taipei Medical University Hospital.
About the Team
Developing a non-invasive in-vitro endometrial cancer kit, including BHLHE22 methylation, with high sensitivity and specificity for endometrial cancer diagnosis.
Completed product specification standards, carried out clinical test in three medical centers, and devised a business plan，On August 7, 2018 formedGuzip Biomarkers Corporation .